Oakwood Capital Management’s Celgene Corp CELG Stock Holding History

Oakwood Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-48,051	Closed	-$4.81M	–	78
2016 Q1	$4.81M	Buy	48,051 +2,030	+4%	+$209K	1.27%	35
2015 Q4	$5.51M	Sell	46,021 -525	-1%	-$60.7K	1.48%	30
2015 Q3	$5.04M	Buy	46,546 +2,133	+5%	+$265K	1.4%	31
2015 Q2	$5.14M	Buy	44,413 +2,335	+6%	+$267K	1.34%	33
2015 Q1	$4.85M	Sell	42,078 -15,496	-27%	-$1.85M	1.33%	31
2014 Q4	$6.44M	Sell	57,574 -8,931	-13%	-$942K	1.83%	13
2014 Q3	$6.3M	Buy	66,505 +1,105	+2%	+$99.7K	1.84%	12
2014 Q2	$5.62M	Buy	65,400 +2,380	+4%	+$181K	1.69%	13
2014 Q1	$4.4M	Buy	63,020 +670	+1%	+$53.1K	1.45%	26
2013 Q4	$5.27M	Buy	62,350 +672	+1%	+$53.2K	1.75%	11
2013 Q3	$4.75M	Buy	61,678 +3,050	+5%	+$214K	1.74%	11
2013 Q2	$3.43M	Buy	+58,628	New	+$3.53M	1.36%	25

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Oakwood Capital Management's CELG Position: Q2 2016 in Review

Oakwood Capital Management sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 48,051 shares — an estimated $4.81M sold.

Oakwood Capital Management first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $6.44M in Q4 2014. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Oakwood Capital Management reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
Oakwood Capital Management sold 48,051 Celgene Corp shares in Q2 2016, an estimated $4.81M.
Oakwood Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
Oakwood Capital Management's Celgene Corp position peaked at $6.44M in Q4 2014.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Oakwood Capital Management's 13F filing for Q2 2016, filed 26 Jul 2016.